Lindbrook Capital, LLC Zoetis Inc. Transaction History

Lindbrook Capital, LLC

$1.18 Billion
Q3 2024

A detailed history of Lindbrook Capital, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Lindbrook Capital, LLC holds 3,585 shares of ZTS stock, worth $585,466. This represents 0.06% of its overall portfolio holdings.

Number of Shares

3,585

Previous 3,547 1.07%

Holding current value

$585,466

Previous $614,000 14.01%

% of portfolio

0.06%

Previous 0.06%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$172.58 - $196.48 $6,558 - $7,466	38 Added 1.07%	3,585 $700,000
Q2 2024 Jul 31, 2024	SELL	$145.54 - $178.83 $93,436 - $114,808	-642 Reduced 15.33%	3,547 $614,000
Q1 2024 Apr 25, 2024	SELL	$165.67 - $199.94 $1,325 - $1,599	-8 Reduced 0.19%	4,189 $708,000
Q4 2023 Jan 31, 2024	BUY	$151.44 - $200.09 $119,031 - $157,270	786 Added 23.04%	4,197 $828,000
Q3 2023 Oct 25, 2023	BUY	$167.14 - $192.77 $6,518 - $7,518	39 Added 1.16%	3,411 $593,000
Q2 2023 Jul 28, 2023	BUY	$160.94 - $186.23 $64,054 - $74,119	398 Added 13.38%	3,372 $580,000
Q1 2023 Apr 26, 2023	SELL	$145.48 - $175.02 $13,820 - $16,626	-95 Reduced 3.1%	2,974 $494,000
Q4 2022 Jan 24, 2023	BUY	$131.14 - $157.47 $73,569 - $88,340	561 Added 22.37%	3,069 $0
Q3 2022 Nov 10, 2022	SELL	$148.29 - $182.55 $20,167 - $24,826	-136 Reduced 5.14%	2,508 $372,000
Q2 2022 Aug 01, 2022	SELL	$155.97 - $200.09 $76,737 - $98,444	-492 Reduced 15.69%	2,644 $454,000
Q1 2022 Apr 21, 2022	SELL	$181.39 - $234.03 $6,530 - $8,425	-36 Reduced 1.13%	3,136 $591,000
Q4 2021 Jan 18, 2022	BUY	$193.69 - $247.03 $312,615 - $398,706	1,614 Added 103.59%	3,172 $774,000
Q3 2021 Nov 05, 2021	SELL	$189.29 - $209.69 $757 - $838	-4 Reduced 0.26%	1,558 $302,000
Q2 2021 Jul 27, 2021	BUY	$155.9 - $187.99 $4,209 - $5,075	27 Added 1.76%	1,562 $291,000
Q1 2021 Apr 28, 2021	SELL	$144.0 - $169.39 $18,000 - $21,173	-125 Reduced 7.53%	1,535 $242,000
Q4 2020 Jan 27, 2021	BUY	$157.07 - $174.35 $27,173 - $30,162	173 Added 11.63%	1,660 $275,000
Q3 2020 Nov 03, 2020	SELL	$137.1 - $165.37 $35,371 - $42,665	-258 Reduced 14.79%	1,487 $246,000
Q2 2020 Jul 27, 2020	SELL	$111.92 - $142.53 $1,343 - $1,710	-12 Reduced 0.68%	1,745 $239,000
Q1 2020 Apr 22, 2020	SELL	$92.66 - $144.94 $7,042 - $11,015	-76 Reduced 4.15%	1,757 $207,000
Q4 2019 Jan 27, 2020	BUY	$116.25 - $133.25 $3,022 - $3,464	26 Added 1.44%	1,833 $243,000
Q3 2019 Oct 31, 2019	BUY	$112.57 - $128.43 $2,476 - $2,825	22 Added 1.23%	1,807 $225,000
Q2 2019 Jul 24, 2019	BUY	$97.98 - $114.28 $2,253 - $2,628	23 Added 1.31%	1,785 $202,000
Q1 2019 Apr 23, 2019	BUY	$81.56 - $100.67 $4,567 - $5,637	56 Added 3.28%	1,762 $177,000
Q4 2018 Feb 07, 2019	BUY	$79.28 - $95.27 $135,251 - $162,530	1,706 New	1,706 $145,000

Others Institutions Holding ZTS

# of Institutions

1,958

Shares Held

410M

Call Options Held

1.02M

Put Options Held

1.09M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $76.5B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.

Account

Lindbrook Capital, LLC Zoetis Inc. Transaction History